Prospector Profile 128-01
|
|
Mindready Solutions, Inc. |
NAICS |
334519 |
2800 Marie-Curie Avenue
Saint-Laurent, Quebec, Canada H4S 2C2 |
Description |
Testing Machines Mfg. |
(514) 339-1394 |
Employees |
336 |
http://www.mindready.com/ |
Revenue |
(mil) |
16.9000 |
|
Income |
(mil) |
-28.7000 |
|
Assets |
(mil) |
16.8000 |
|
Liability |
(mil) |
12.1000 |
|
(for the year ended 2005-12-31) |
|
Category:
Bankruptcy
|
|
Event:
Mindready Solutions, Inc. announced that it has sought protection from its creditors under the Bankruptcy and Insolvency Act. The Debtor filed a notice of intention to make a proposal to its creditors. Following the filing, all directors have resigned.
|
|
Intellectual Property:
The Company possesses intellectual property rights for products based on the IEEE-
1394/FireWire® communications standard, including “SEDNET”, which is used in the marketing and sale of these products. "SEDNET" is a trademark of the Company, registered in both Canada and the United States. In addition, the Company possesses the rights in respect of the trademark “MINDREADY” which is registered in Canada and in the United States. It is the Company's practice to enter into non-disclosure agreements with employees and third parties and to restrict access to its software-product source codes. The Company regards its source codes as proprietary information and attempts to protect the source code versions of its products, as well as documentation and other written materials, as trade secrets and unpublished copyrighted works. [Company Website]
|
|
Description:
Mindready is a leading supplier of innovative test engineering, manufacturing automation and real-time communications solutions. Mindready has developed a unique expertise in helping its OEM and EMS clients design, manufacture and test their complex electronic products.
|
|
Officers:
Michel Gaucher (Chair); Claude Delage (Pres., CEO & Dir.); Marc Lamy (VP, CFO & Dir.); Jean-François Rabouille (VP & Dir.)
|
|
Auditor:
KPMG LLP
|
|
Securities:
Common Stock-Symbol MDREF.PK; Other OTC.
|
|
|
|
return to main page |